TNX-102 SL, a sublingual cyclobenzaprine HCl formulation, is safe and effective for treating fibromyalgia symptoms, according to study results presented at the American College of Rheumatology (ACR) ...

A former security officer with fibromyalgia was unable to convince the First Circuit that the Transportation Security ...

Founded with a mission to address the “last-mile” challenges in pain relief, Doloromics integrates artificial intelligence ...

Dec. 22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia. Both forms of treatment produced a ...

(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) presented data at the ACR Convergence 2024 Annual Meeting showcasing the success of its Phase 3 RESILIENT study for TNX-102 SL, a ...

Cannabis enthusiasts are increasingly turning to THCA concentrates for their non-psychoactive therapeutic properties. THCA, ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced that Chief Operating Officer Jessica Morris will present at the Winter 2024 Investor Summit Virtual ...

Tonix Pharmaceuticals (TNXP) presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, held November 14-19, 2024, in ...

Emma Swenson left KU after one semester after her chronic health issues became worse after living in the dorms. Swenson now ...

Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

While many people living with chronic pain require medication, there is growing interest in non-pharmacological approaches ...